Strategic partnerships Modulim has already formed a strategic alliance with Satellite Healthcare to standardize the use of its LAMP solution, signaling a path for expanding into managed care and integrated care networks.

Clinical impact The Clarifi Imaging System targets microvascular dysfunction to prevent complications like diabetic foot ulcers and amputations, highlighting a clear value proposition for wound care, endocrinology, nephrology, and vascular clinics seeking early intervention tools.

Reimbursement readiness Clarifi imaging is supported by a CPT PLA code (0061U), indicating reimbursement alignment that can reduce adoption friction and facilitate payer conversations during market expansion into new specialties.

Market expansion With leadership in optical imaging and focus on noninvasive tissue assessment, there are opportunities to upsell to high-risk CKD/ESRD programs, vascular clinics, diabetes care groups, and post-acute care facilities seeking limb-salvage capabilities.

Growth signals Recent leadership and PR activity, including hires in marketing and executives, alongside a track record of funding and a customer-adoption narrative, suggest a scalable sales motion that can be leveraged for enterprise pilots and regional expansion.